Provided By GlobeNewswire
Last update: Feb 2, 2024
Findings support positive proof of mechanism, through successful degradation of methionine, precursor to homocysteine, using dietary disease model in preclinical models and healthy volunteer study
NASDAQ:SYBX (8/22/2025, 8:00:00 PM)
1.46
+0.06 (+4.29%)
Find more stocks in the Stock Screener